Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:41:02 EDT Tue 16 Apr 2024
Enter Symbol
or Name
USA
CA



News for C:ONC from 2023-04-17 to 2024-04-16 - 31 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-04-05 07:12C:ONCOncolytics Biotech Inc (2)1.56In the NewsGlobe says Oncolytics Biotech kept at "outperformer"
2024-03-12 16:33C:ONCOncolytics Biotech Inc (2)1.43SEDAR Annual ReportSEDAR Annual Report
2024-03-07 19:18C:ONCOncolytics Biotech Inc (2)1.41SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-07 19:18C:ONCOncolytics Biotech Inc (2)1.41SEDAR MD & ASEDAR MD & A
2024-03-07 16:22C:ONCOncolytics Biotech Inc (2)1.41News ReleaseOncolytics spends $17.7-million on R&D in 2023
2024-03-05 10:34C:ONCOncolytics Biotech Inc (2)1.37News ReleaseOncolytics files amendment to Goblet phase 1/2 study
2024-03-04 10:48C:ONCOncolytics Biotech Inc (2)1.51News ReleaseOncolytics Biotech to release 2023 results March 7
2024-02-14 11:37C:ONCOncolytics Biotech Inc (2)1.41News ReleaseOncolytics expands Goblet anal cancer study enrolment
2024-01-09 10:31C:ONCOncolytics Biotech Inc (2)1.81News ReleaseOncolytics Biotech appoints Andrews as director
2024-01-04 09:40C:ONCOncolytics Biotech Inc (2)1.76News ReleaseOncolytics Biotech recaps 2023 operations
2023-12-07 10:16C:ONCOncolytics Biotech Inc (2)1.91News ReleaseOncolytics presents AWARE-1 data at cancer symposium
2023-11-09 10:43C:ONCOncolytics Biotech Inc (2)1.82News ReleaseOncolytics presents Goblet results at IMACC in Rome
2023-11-09 10:03C:ONCOncolytics Biotech Inc (2)2.15News ReleaseOncolytics plans to start phase 3 PDAC study mid-2024
2023-11-03 13:38C:ONCOncolytics Biotech Inc (2)2.35News ReleaseOncolytics Biotech presents Aware-1 study data
2023-11-03 11:33C:ONCOncolytics Biotech Inc (2)2.43SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-03 11:31C:ONCOncolytics Biotech Inc (2)2.43SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-03 11:23C:ONCOncolytics Biotech Inc (2)2.35News ReleaseOncolytics Biotech's Sept. 30 cash at $40-million
2023-10-23 11:04C:ONCOncolytics Biotech Inc (2)2.30News ReleaseOncolytics talks Goblet pancreatic cancer study data
2023-10-23 10:18C:ONCOncolytics Biotech Inc (2)2.14News ReleaseOncolytics' Goblet study meets efficacy criteria
2023-10-20 08:06C:ONCOncolytics Biotech Inc (2)2.22News ReleaseOncolytics Biotech to release Q3 2023 results Nov. 3
2023-09-26 10:06C:ONCOncolytics Biotech Inc (2)3.00News ReleaseOncolytics Biotech receives $5-million research grant
2023-08-14 12:28C:ONCOncolytics Biotech Inc (2)2.76News ReleaseOncolytics Biotech spends $3.7M on R&D in Q2 2023
2023-08-14 10:17C:ONCOncolytics Biotech Inc (2)2.73SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-04 07:57C:ONCOncolytics Biotech Inc (2)3.01News ReleaseOncolytics Biotech to hold Q2 2023 results call Aug. 14
2023-08-03 21:51C:ONCOncolytics Biotech Inc (2)3.01Prospectus ApprovedOncolytics Biotech to list additional shares Aug. 8
2023-06-22 09:09C:ONCOncolytics Biotech Inc (2)2.81News ReleaseOncolytics' pelareorep selected for Precision trial
2023-06-05 09:52C:ONCOncolytics Biotech Inc (2)2.28News ReleaseOncolytics talks Bracelet-1 phase 2 trial results
2023-05-10 12:35C:ONCOncolytics Biotech Inc (2)2.19News ReleaseOncolytics shareholders approve all matters at AGM
2023-05-05 10:30C:ONCOncolytics Biotech Inc (2)1.98SEDAR MD & ASEDAR MD & A
2023-05-05 10:28C:ONCOncolytics Biotech Inc (2)1.98SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-05 10:02C:ONCOncolytics Biotech Inc (2)2.14News ReleaseOncolytics Biotech spends $3.5-million on R&D in Q1